EMECX
Price
$10.44
Change
+$0.04 (+0.38%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

EMECX vs RNWFX

Header iconEMECX vs RNWFX Comparison
Open Charts EMECX vs RNWFXBanner chart's image
Ashmore Emerging Markets Equity C
Price$10.44
Change+$0.04 (+0.38%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
EMECX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMECX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMECX is a Hold and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. EMECX (156M). RNWFX pays higher dividends than EMECX: RNWFX (1.51) vs EMECX (0.51). EMECX was incepted earlier than RNWFX: EMECX (12 years) vs RNWFX (23 years). EMECX is a more actively managed with annual turnover of: 79.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than EMECX: RNWFX (250) vs EMECX (1000). EMECX annual gain was more profitable for investors over the last year : 8.91 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. EMECX (-7.06).
EMECXRNWFXEMECX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD7.6774.549169%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets156M62.2B0%
Annual Yield % from dividends0.511.5134%
Returns for 1 year8.915.86152%
Returns for 3 years-11.82-5.10232%
Returns for 5 years-7.0614.39-49%
Returns for 10 years12.4142.6729%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics